Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
about
Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United StatesEpstein-Barr virus-associated lymphoid malignancies: the expanding spectrum of hematopoietic neoplasmsSpectrum of Epstein-Barr virus-associated T-cell lymphoproliferative disorder in adolescents and young adults in Taiwan.Novel mouse xenograft models reveal a critical role of CD4+ T cells in the proliferation of EBV-infected T and NK cells.Long-term remission in a child with refractory EBV(+) hydroa vacciniforme-like T-cell lymphoma through sequential matched EBV(+)-related allogeneic hematopoietic SCT followed by donor-derived EBV-specific cytotoxic T-lymphocyte immunotherapy.P-glycoprotein is expressed and causes resistance to chemotherapy in EBV-positive T-cell lymphoproliferative diseasesA rapid increase in the normal white cell counts without blasts as the initial presentation of T-cell acute lymphoblastic leukaemia.Extranodal natural killer/T-cell lymphoma: current concepts in biology and treatment.Risk stratification in extranodal natural killer/T-cell lymphoma.Diagnosis and management of natural killer-cell malignancies.Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disorder in children and young adults has similar molecular signature to extranodal nasal natural killer/T-cell lymphoma but shows distinctive stem cell-like phenotype.Effect of reduced-intensity conditioning and the risk of late-onset non-infectious pulmonary complications in pediatric patients.Haploidentical hematopoietic stem cell transplantation for adult patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.Treatment choice of immunotherapy or further chemotherapy for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.Epstein-Barr-Virus-Positive B-Cell Lymphoma of Recipient Origin Despite of the Elimination of Clonally EBV-Infected T Cells by Allogeneic Stem Cell Transplantation in a Patient with Chronic Active EBV Infection.Pediatric T- and NK-cell lymphomas: new biologic insights and treatment strategies.Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008.Resolution of chronic active EBV infection and coexisting pulmonary arterial hypertension after cord blood transplantation.A case series of CAEBV of children and young adults treated with reduced-intensity conditioning and allogeneic bone marrow transplantation: a single-center study.Excellent outcome of allogeneic hematopoietic SCT with reduced-intensity conditioning for the treatment of chronic active EBV infection.Biopsy-proven case of Epstein-Barr virus (EBV)-associated vasculitis of the central nervous system.Successful disease control with L-asparaginase monotherapy for aggressive natural killer cell leukemia with severe hepatic failure.Hemophagocytic lymphohistiocytosis: Pathogenesis, diagnosis, and management.Current research on chronic active Epstein-Barr virus infection in Japan.Clinical features of adult patients with secondary hemophagocytic lymphohistiocytosis from causes other than lymphoma: an analysis of treatment outcome and prognostic factors.Hematopoietic Stem Cell Transplantation for the Treatment of Epstein-Barr Virus-Associated T- or NK-Cell Lymphoproliferative Diseases and Associated Disorders
P2860
Q24617384-B2A5BCCE-1CA2-4C26-9F0E-5E8F3A275B09Q26824570-38B51883-B708-4F29-A34E-2796E85E286EQ33802728-C6805742-308E-469B-AEDA-6648CA890E15Q34058148-69680C29-371B-4B2D-8BB8-D44175331ADEQ35219963-165BDCAB-5B6C-413F-9652-8211E5775192Q36201459-B2F28CCE-4C31-4CFA-BD17-2BEE56FC619FQ37078199-6B96B5BF-DFB0-4530-9053-D11CE0A32595Q37626051-E8C29A62-7995-495E-9608-D0211520BCADQ37788238-7A9003DB-50BC-403B-BA65-021CDC5A0259Q37810280-F8BA4BB0-E486-42D9-A1CF-7DA98EB2051BQ38941606-532A6AC3-DD6D-49A1-AF60-D98AA4E8BD12Q40059402-AAE24502-06FD-48C0-9900-0485317C3B3BQ40176181-96538FC4-238B-4712-BA55-FDF68D6E6041Q40302112-BF40032B-4AA6-4F0D-ACFE-1A3AF094D7D7Q41726155-5113DC79-474E-4136-A64C-F31F3E668AB4Q41942675-63973AC7-1E95-4F45-AEB2-BCE8623C0B30Q43065304-BD68090A-80D3-425D-BD42-E22348007A0DQ43452913-8A11121B-DB88-4BFB-92AC-7E247824D1FDQ43647077-143BE27C-EF71-44A5-A9BE-CC2C2C135869Q44766035-D4D97315-0FB0-4A4E-9434-E54EFC65AD56Q45331358-46414075-5E0B-45D8-B9D8-4240B8D976A0Q45802969-F653EE1F-1257-4018-A07B-4E107C2A4F11Q51707712-616B789F-0D3E-40C8-BB50-CF83AADD5DB8Q51849571-217702C3-A302-408D-9199-EC5A18C2A59DQ53395475-4B21E666-F679-4FC7-8F6F-ACA0EF15852AQ59128393-57898D65-8DBE-4692-8D3D-91D5DF4AFDD1
P2860
Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Allogeneic hematopoietic stem ...... roliferative disease in Japan.
@en
Allogeneic hematopoietic stem ...... roliferative disease in Japan.
@nl
type
label
Allogeneic hematopoietic stem ...... roliferative disease in Japan.
@en
Allogeneic hematopoietic stem ...... roliferative disease in Japan.
@nl
prefLabel
Allogeneic hematopoietic stem ...... roliferative disease in Japan.
@en
Allogeneic hematopoietic stem ...... roliferative disease in Japan.
@nl
P2093
P2860
P356
P1476
Allogeneic hematopoietic stem ...... proliferative disease in Japan
@en
P2093
Emiko Sato
Fumiaki Yoshiba
Hiroshi Kuroda
Keisei Kawa
Masami Inoue
Miki Nishimura
Shouichi Ohga
P2860
P304
P356
10.1002/AJH.21247
P50
P577
2008-09-01T00:00:00Z